A South Korean lettuce variety called heukharang or black harang, which serves as a natural treatment for insomnia is set for cultivation in Australia.
Jeollanamdo Agricultural Research & Extension Services (JARES) developed heukharang, which contains 3.74 milligrams of sleep-inducing lactucin per gram, or 124 times more than regular lettuce.
As the lactucin in regular lettuce is not potent enough to counter insomnia, an adult weighing 60 kilograms would need to consume 4 kilograms of it to induce sleep.
Heukharang would require much less consumption to achieve the desired results.
According to JARES, the Korean chemical firm Isu Chemical Co. has agreed to produce and sell heukharang lettuce in Australia.
Since Australia has strict quarantine laws for imported food but allows the importation of seeds, Isu Chemical Co. has to cultivate heukharang in Australia.
With its high gross national income and high prevalence of adult sleep disorders., Australia is a promising market for high-value-added and functional vegetables like heukharang.
Meanwhile. South Korea's market for insomnia treatment was estimated to be worth 40 billion won in 2020 and has been expanding at more than 5 percent annually.


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
NASA and SpaceX Target Crew-11 Undocking From ISS Amid Medical Concern
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Yes, government influences wages – but not just in the way you might think
What’s the difference between baking powder and baking soda? It’s subtle, but significant
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
6 simple questions to tell if a ‘finfluencer’ is more flash than cash
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
How to support someone who is grieving: five research-backed strategies
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Every generation thinks they had it the toughest, but for Gen Z, they’re probably right
The pandemic is still disrupting young people’s careers
Debate over H-1B visas shines spotlight on US tech worker shortages
Australia’s December Trade Surplus Expands but Falls Short of Expectations 



